Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
08/2002
08/29/2002US20020119960 Drug resistance therapy
08/29/2002US20020119910 Drug delivery
08/28/2002EP1234817A1 A process for the preparation of midodrine
08/28/2002EP1019363B1 Process for the preparation of an inorganic salt of an optically active phenylglycine derivative
08/28/2002EP1017734B1 Crosslinkable polyurea polymers
08/28/2002CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor
08/28/2002CN1089775C Polyblend of structured copolymers used as absorbents, gels and carriers of metal ions
08/27/2002US6441235 Preparation of 5-amino-isophthalamides
08/27/2002US6441177 (4-bromo-phenyl)-(4-(6-(cyclopropyl-methyl-amino)-hexyloxy)-2-fluoro -phenyl)-methanone; antimycotic and cholesterol lowering activity
08/27/2002US6440405 Quaternary ammonium functionalized dendrimers and methods of use therefor
08/27/2002CA1341386C Acid-labile anchor groups for the synthesis of peptide amides by a solid-phase method
08/26/2002CA2366311A1 A process for the preparation of midodrine
08/22/2002WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors
08/22/2002WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002WO2002032869A3 Substituted heterocyclic compounds for treating multidrug resistance
08/22/2002WO2002004412A3 Tyrosine derivatives as phosphatase inhibitors
08/22/2002US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects
08/22/2002US20020115659 Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance
08/22/2002US20020115644 Tetracycline compounds for treatment of Cryptosporidium parvum related disorders
08/22/2002US20020115612 High-speed automated solid-phase synthesis repeating steps of acylation of a resin-bound secondary amine with haloacetic acid followed by nucleophilic displacement of the halogen by an N-substituted amine; libraries
08/22/2002US20020115600 Inhibitors of memapsin 2 and use thereof
08/22/2002CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors
08/21/2002EP1232168A2 Synthetic lipid-a analogs and uses thereof
08/21/2002EP1231919A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
08/21/2002CN1365354A Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
08/21/2002CN1089335C Process for purifying intermediate in preparation of iopamidol
08/20/2002US6437145 Reacting n-protected aminodicarboxylic acids with a dehydrating agent to form cyclic anhydrides which are reacted with carbonyl compounds; for the alpha-selective production of esters or amides of dicarboxylic amino acids
08/20/2002US6436925 Better able to cross membranes; inhibitors of cysteine proteases like calpain i and ii and cathepsin b and l, can thus be used to control diseases associated with an elevated activity of calpain enzymes or cathepsin enzymes
08/20/2002US6436152 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/20/2002CA2088367C Tri- and tetra-valent monospecific antigen-binding proteins
08/20/2002CA2083405C Polyaspartic acid as a calcium carbonate and a calcium phosphate inhibitor
08/15/2002WO2002062778A2 Anti-thrombotic compounds, production and use thereof as medicaments
08/15/2002WO2002062746A1 Novel n-alkylaspartylamide derivative and sweetener
08/15/2002WO2002028821A3 Propionic acid derivatives with ppar-alpha activating properties
08/15/2002WO2001072685B1 Polyamine analogues as cytotoxic agents
08/15/2002US20020111364 ABCA-1 elevating compounds
08/15/2002US20020111338 Bile-acid conjugates for providing sustained systemic concentrations of drugs
08/15/2002US20020111335 Bactericides, bacteriostats
08/15/2002CA2437655A1 Novel n-alkylaspartyl amide derivative and sweetening agent
08/15/2002CA2435492A1 Antithrombotic compounds, the preparation thereof and their use as pharmaceutical compositions
08/14/2002EP1230260A1 Hcv ns3 protease inhibitors
08/14/2002EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders
08/14/2002EP1229977A1 Polyamide-containing ligands covalently bonded to supports, polyamide-containing resins, and methods for removing metals from solutions
08/14/2002EP0722439B1 Hiv protease inhibitors
08/14/2002DE10105014A1 Neues Verfahren zur Herstellung von Monoamiden der DTPA New process for the preparation of monoamides of the DTPA
08/14/2002CN1364153A Substituted phenoxyacetic acids
08/14/2002CN1088992C Topically administrable compositions containing 2-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
08/13/2002US6433017 Amphiphilic polyamine compounds
08/13/2002US6432933 Malaria therapy; alzheimer's disorders
08/13/2002US6432923 Antiinflammatory agents; autoimmune diseases
08/13/2002US6432921 Oligopeptides
08/13/2002CA2167524C Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
08/08/2002WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity
08/08/2002WO2001077068A3 Process for preparing 6-aminocaproamide
08/08/2002US20020107406 Calcium receptor-active compounds
08/08/2002CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity
08/07/2002EP1229010A1 Novel diarylamide derivatives and use thereof as medicines
08/07/2002EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
08/07/2002EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
08/07/2002EP0984922B1 Preparation of tri-iodo benzene compounds
08/07/2002EP0680495B1 Structured copolymers used as carriers of metal ions
08/07/2002EP0636183B1 Compositions and methods for protein structural determinations
08/07/2002CN1088585C Compound active at novel site on receptor-operated calcium channels use full for treatment of neurological disorders and diseases
08/06/2002US6428780 Modified amino acid
08/01/2002WO2002059077A1 Aminoethanol derivatives
08/01/2002WO2002059076A1 Method for producing dtpa monoamides
08/01/2002US20020103215 Beta-aryl-alpha-oxysubstituted alkylcarboxylic acids; antiobesity and hypocholesterolemic compounds
08/01/2002US20020103171 7-and 9- carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
07/2002
07/31/2002EP1226109A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents
07/31/2002EP1226104A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents
07/31/2002EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
07/31/2002EP0799059B1 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
07/31/2002EP0719267B1 Second messenger cell signaling inhibitors
07/31/2002CN1361763A Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
07/30/2002US6426059 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
07/30/2002CA2291067C Method for the preparation of citalopram
07/30/2002CA2148683C Potentiator of bacillus pesticidal activity
07/25/2002WO2002057298A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
07/25/2002WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance
07/25/2002WO2001000665A9 Inhibitors of memapsin 2 and use thereof
07/25/2002US20020099215 For therapy and prophylaxis of P-glycoprotein-mediated multidrug resistance
07/25/2002US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases
07/25/2002US20020098999 Compounds for sustained release of orally delivered drugs
07/25/2002US20020098152 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
07/25/2002CA2433879A1 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
07/24/2002EP1224164A1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23
07/24/2002EP1102743B1 Amide derivatives which are useful as cytokine inhibitors
07/24/2002EP0836485B1 Cascade polymer complexes
07/23/2002US6423869 Polyol-amino acid compounds having anti-helicobacter pylori activity
07/18/2002WO2002055485A1 Prodrugs of excitatory amino acids
07/18/2002WO2002055481A1 Prodrugs of excitatory amino acids
07/18/2002WO2001072685A3 Polyamine analogues as cytotoxic agents
07/18/2002US20020095053 Di-lower-alkyl-5-nitroisophthalate reacts with a dihydroxy-monoalkylamine in the presence of a basic catalyst and then catalylytically hydrogenated, without isolating the 5-nitro-N,N'-bis(R)isophthalamide intermediate
07/17/2002EP1222163A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
07/17/2002EP1222152A1 A method for preparing and screening one or more compounds
07/17/2002EP1039902A4 Inhibitors of gap junction communication
07/17/2002CN1359403A Diaminobenzene derivative, polyimide obtained thereform, and liquid-crystal alignment film
07/17/2002CN1359371A Benzamide derivatives for the treatment of diseases mediated by cytokines
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 162